We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VINC market cap is 238.68k. The company's latest EPS is USD -5.7456 and P/E is -0.01.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.48M | -7.37M | -7.79M | -8.83M | -3.33M |
| Net Income | -12.43M | -1.81M | -7.84M | -7.99M | -5M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.71M | -62.66M | -73.57M | -42.61M | -31.46M |
| Net Income | -10.72M | -39.31M | -65.37M | -40.16M | -30.07M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 11.08M | 21.53M | 14.95M | 8.01M | 4.69M |
| Total Liabilities | 11.71M | 6.08M | 5.84M | 5.28M | 2.62M |
| Total Equity | -622k | 15.45M | 9.11M | 2.72M | 2.07M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 63.19M | 117.68M | 59.29M | 18.22M | 8.01M |
| Total Liabilities | 5.51M | 17.36M | 11.62M | 7M | 5.28M |
| Total Equity | 57.69M | 100.32M | 47.67M | 11.22M | 2.72M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.74M | -13.57M | -19.95M | -26.13M | -4.45M |
| Investing | N/A | -8.34M | -6.96M | 212k | N/A |
| Financing | 5k | 17.01M | 17.01M | 17.99M | 3.86M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.28M | -33.4M | -59.6M | -40.45M | -26.13M |
| Investing | N/A | -5.26M | -40.58M | 41.5M | 212k |
| Financing | 64.07M | 88.45M | 280k | 114k | 17.99M |
| Market Cap | 238.68k |
| Price to Earnings Ratio | -0.01 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.08 |
| Price to Book Ratio | 0.15 |
| Dividend Yield | - |
| Shares Outstanding | 5.23M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -99.68% |
| 52 Week High | 17.172 |
| 52 Week Low | 0.045 |
| Spread (Intraday) | 0.01 (21.07%) |
| Company Name | Vincerx Pharma Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://vincerx.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
